Treatment Patterns, Clinical Outcomes and Health Care Resource Utilisation in Patients with EGFR-mutated Metastatic Non-Small Cell Lung Cancer: A Real-World Study in South Korea.
Cliff MolifeJae Min ChoJennifer LapthornMin Ju KangYulia D'yachkovaSangmi KimSam ColmanSaerom KimAgota SzendeJi Hyun ParkHee Kyung AhnMin Hee HongKaisa-Leena TaipaleHye Ryun KimPublished in: Drugs - real world outcomes (2022)
Characteristics and clinical outcomes of Korean patients with EGFRm+ mNSCLC in real-world practice were comparable to those observed in clinical trials. As osimertinib was not reimbursed for first-line treatment before study completion, further investigation is warranted to explore evolving treatment practice.